ABCL
Abcellera Biologics Inc
Clinical-stage biotechnology company discovering and developing antibody-based medicines
CUSIP: 00288U106HealthcareUS1 holder
Total Value
$775.98M
Total Shares
19.28M
Net Share Change
+19.28M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$775.98M19.28M sharesNEW